Myung-Ju Ahn

Myung-Ju Ahn is one of Korea's most distinguished thoracic oncologists who has been a principal investigator on multiple international lung cancer trials, including SCLC studies. She has contributed to the clinical evidence base for immunotherapy in SCLC and NSCLC and is prolific in translational research on lung cancer molecular biology. She has served on editorial boards of leading oncology journals and contributed to ESMO and IASLC guideline development. Her clinical trial infrastructure has positioned Samsung Medical Center as a leading site for lung cancer research in Asia.